Portal de Periódicos da CAPES

Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia

2002; Wiley; Volume: 44; Issue: 5 Linguagem: Inglês

10.1046/j.1442-200x.2002.01594.x

1442-200X

Hideyo Kinugasa, Hitoshi Horigome, Masatoshi Sugiura, Takashi Saito, Tatsuo Iijima, Akira Matsui,

Pulmonary Hypertension Research and Treatments

Pediatrics InternationalVolume 44, Issue 5 p. 525-527 Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia Hideyo Kinugasa, Hideyo Kinugasa Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this authorHitoshi Horigome, Hitoshi Horigome Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this authorMasatoshi Sugiura, Masatoshi Sugiura Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this authorTakashi Saito, Takashi Saito Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this authorTatsuo Iijima, Tatsuo Iijima Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Tennodai, Tsukuba, JapanSearch for more papers by this authorAkira Matsui, Akira Matsui Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this author Hideyo Kinugasa, Hideyo Kinugasa Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this authorHitoshi Horigome, Hitoshi Horigome Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this authorMasatoshi Sugiura, Masatoshi Sugiura Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this authorTakashi Saito, Takashi Saito Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this authorTatsuo Iijima, Tatsuo Iijima Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Tennodai, Tsukuba, JapanSearch for more papers by this authorAkira Matsui, Akira Matsui Department of Pediatrics, Institute of Clinical Medicine andSearch for more papers by this author First published: 22 October 2002 https://doi.org/10.1046/j.1442-200X.2002.01594.xCitations: 7 (present address): Hideyo Kinugasa MD, Department of Pediatrics, Ibaraki Prefectural University of Health Sciences, 4669-2 Ami, Ami-cho, Inashiki-gun, Ibaraki, Japan. Email: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Janney CG, Askin FB, Kuhn C. Congenital alveolar capillary dysplasia − an unusual cause of respiratory distress in the newborn. Am. J. Clin. Pathol. 1981; 76: 722−7. 10.1093/ajcp/76.5.722 CASPubMedWeb of Science®Google Scholar 2 Al-Hathlol K, Phillips S, Seshia MMK, Casiro O, Alvaro RE, Rigatto H. Alveolar capillary dysplasia. Report of a case of prolonged life without extracorporeal membrane oxygenation (ECMO) and review of the literature. Early Hum. Dev. 2000; 57: 85−94. 10.1016/S0378-3782(99)00065-1 CASPubMedWeb of Science®Google Scholar 3 Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease: A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18: 533−47. 10.1161/01.CIR.18.4.533 CASPubMedWeb of Science®Google Scholar 4 Steinhorn RH, Cox PN, Fineman JR et al. Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J. Pediatr. 1997; 130: 417−22. 10.1016/S0022-3476(97)70203-8 CASPubMedWeb of Science®Google Scholar 5 Parker TA, Ivy DD, Kinsella JP et al. Combined therapy with inhaled nitric oxide and intravenous prostacyclin in an infant with alveolar-capillary dysplasia. Am. J. Respir. Crit. Care Med. 1997; 155: 743−6. 10.1164/ajrccm.155.2.9032222 PubMedWeb of Science®Google Scholar 6 Kerstein D, Levy PS, Hsu DT, Hordof AJ, Gersony WM, Barst RJ. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 1995; 91: 2028−35. 10.1161/01.CIR.91.7.2028 CASPubMedWeb of Science®Google Scholar 7 Wanstall JC, Jeffery TK. Recognition and management of pulmonary hypertension. Drugs 1998; 56: 989−1007. 10.2165/00003495-199856060-00004 CASPubMedWeb of Science®Google Scholar 8 Roberts JD, Chiche JD, Weimann J, Steudel W, Zapol WM, Bloch KD. Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Circ. Res. 2000; 87: 140−5. 10.1161/01.RES.87.2.140 CASPubMedWeb of Science®Google Scholar 9 Galiè N. Prostacyclin in primary pulmonary hypertension. Eur. Heart J. 1996; 17: 18−24. 10.1093/oxfordjournals.eurheartj.a014686 PubMedWeb of Science®Google Scholar 10 Starnes VA, Oyer PE, Bernstein D et al. Heart, heart-lung, and lung transplantation in the first year of life. Ann. Thorac. Surg. 1992; 53: 306−10. 10.1016/0003-4975(92)91338-A CASPubMedWeb of Science®Google Scholar Citing Literature Volume44, Issue5October 2002Pages 525-527 ReferencesRelatedInformation